Caplight Directory>Companies>Waiv-preview>Wearewaiv


Waiv

Waiv

Private
ParisHealthcare & Life Scienceshttps://wearewaiv.com/

Last Round

Early Funding

Mar 12, 2026

Total Funding Raised

$33M

Company Overview

Waiv is a health technology company that provides an AI-powered precision testing platform for oncology.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Precision Medicine, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

AI diagnosticscomputational pathologydigital pathologyprecision medicineAI biomarker discoveryoncology diagnosticspatient stratificationpathology softwareMSI screeningbreast cancer diagnosticsclinical trial supportcolorectal cancer diagnosticslab workflow integrationCE-IVD markingper-test pricing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Waiv Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Waiv Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 12, 2026
View all Funding Rounds

Waiv Investors

Notable investors and investment history

InvestorRounds
SISTAFUNDEarly Funding
Alpha Intelligence CapitalEarly Funding
OTB VenturesEarly Funding
Serena Data VenturesEarly Funding
KaristaEarly Funding
View all Investors

Waiv Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Waiv Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Waiv's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Year Founded2026
Last FundingMar 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.